American Journal on Addictions

Papers
(The TQCC of American Journal on Addictions is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
2023 Reviewer List (n = 223)123
Comparing substance use treatment initiation and retention between telehealth delivered during COVID‐19 and in‐person treatment pre‐COVID‐1947
Self assessment ad (002)22
CME Posters (n = 64)22
Issue Information ‐ ToC21
Call for special issue 202220
Call for review papers 202319
2022 Self‐Assessment examination16
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients15
Stand against stigma14
Call for review papers 202314
Call for review papers 202313
Stimulants PIP Ad13
Issue Information12
Issue Information ‐ Editorial Board12
Issue Information12
Issue Information ‐ ToC11
AAAP on‐demand educational activities11
Prescription Drug Monitoring Program: Access in the First Year10
10
Addiction Psychiatry Advanced Psychotherapy Curriculum9
Issue Information8
2022: The Year in Review8
8
Call for Review Papers 20237
Call for special issue 20226
Persistence of Operant Responding for Food After Prior Cocaine Exposure in Fischer 344 But Not Lewis Rats6
Issue Information6
AAAP's Annual Meeting and Scientific Symposium6
Issue Information6
Is your AAAP Membership expiring this month?6
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem6
Is your AAAP membership expiring soon?6
Issue Information ‐ ToC6
Issue Information6
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression6
Issue Information ‐ ToC5
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances5
Parental influences on tobacco use and likelihood of future use among sexual minority young adult men and women in the United States5
Stand against stigma5
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey5
Do veterans with risky substance use (RSU) use distinct pain treatment modalities?5
Become a AAAP Member5
Issue Information ‐ Editorial Board5
AAAP 36th Annual Meeting & Scientific Symposium Save the Date5
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada5
Motivational Interviewing PIP5
5
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort4
Cannabis Use PIP Ad4
Call for review papers 20234
Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs4
Years of life lost to drug overdose in the Latinx community during the most recent wave of overdose deaths4
Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States4
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic4
4
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?4
Risk factors for poor progression of addictive internet use across different COVID‐19 periods in China4
Call for special issue 20234
Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic4
AJA Stand Against Stigma4
Trends in cocaine use among United States females of reproductive age, 2005–20193
Concurrent Paper Sessions3
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US3
Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes3
Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit3
Call for Special Issue 20243
Brief Report: The Impact of COVID‐19 on Emergency Department Overdose Diagnoses and County Overdose Deaths3
Gender differences in the prevalence of stimulant misuse in the United States: 2015–20193
Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine3
Prevalence, correlates, and consequences of attention‐deficit/hyperactivity disorder in a clinical sample of adults with tramadol use in Egypt3
AAAP Annual Meeting Save the Date3
Medication Management for Stimulant Use Disorder Webinar3
Addiction Psychiatry Advanced Psychotherapy Curriculum3
Predictors of abstinence maintenance after cocaine inpatient detoxification: A prospective study3
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial3
2024 Annual Meeting Posters2
Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder2
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–20212
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study2
Symposium I2
Commentary: It Is Not About Supply, It Is About Demand: Why the Self‐Medication Hypotheses Is Still So Important2
Issue Information2
Mini‐Symposia II2
AAAP Stimulant Use Disorder PIP2
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment2
Daily cannabis use may cause cannabis‐induced hyperalgesia2
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey2
Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts2
Issue Information ‐ Editorial Board2
Save the Date AM 20242
AAAP 36th Annual Meeting & Scientific Symposium Save the Date2
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States2
Interactive effects of ARRB2 and CHRNA5 genetic polymorphisms on cognitive function in Chinese male methamphetamine use disorder patients2
AATT AAP on‐demand2
Become a member of AAAP!2
Advanced Addiction Psychopharmacology1
AAAP Annual meeting ad1
AAAP Membership benefits1
Alcohol use disorder, cannabis use disorder, and eating disorder symptoms among male and female college students1
AAAP 31st Annual Meeting 2020 ‐ Meeting Recap1
Sexual minority disparities in opioid and benzodiazepine misuse among adults with opioid use disorder1
Call for Special Issue 20211
Opioid use disorder and its association with self‐reported difficulties participating in social activities1
Call for Review Papers 20241
Call for special issue 20231
AM Registration Flyer1
Gender differences among persons entering medication treatment for opioid use disorder in the community1
AAAP's Self‐Assessment Examination 20201
Adult self‐reported childhood maltreatment types are associated with treatment satisfaction and alcohol relapse in patients with comorbid substance use and mental health disorders1
AAAP_Call for Special Issue Papers‐20241
Issue Information1
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report1
Posters1
Discrimination experiences and problematic alcohol and cannabis use in young adulthood1
Issue Information1
Issue Information1
Is your AAAP Membership expiring this month?1
AAAP PIPS 20231
Issue Information ‐ Editorial Board1
Associations between muscle‐building exercise and alcohol use behaviors among adolescent boys: Results from the 2019 Youth Risk Behavior Survey1
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center1
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder1
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder1
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder1
Issue Information1
Age of gambling onset and resultant gambling behavior during young adulthood in the United States1
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program1
Barriers to recovery for medical professionals: Assessing financial support through a survey of Physician Health Programs1
Issue Information1
2021 Annual Meeting Poster1
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?1
AAAP's Self‐Assessment Examination 20201
Opioid use disorder in the active service: Implications for intervention1
Opioid Response Network1
Call for review papers 20221
Is your AAAP Membership expiring this month?1
Narcotics Anonymous members in recovery from methamphetamine use disorder1
Educating the community about the opioid epidemic and medications for opioid use disorder1
AAAP Membership1
Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use1
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use1
A cross‐sectional study: Nitrous oxide abuse in Parisian medical students1
Clinical correlates of drug‐related dreams in opioid use disorder1
Stimulants Performance in Practice1
Exploring the intersection of sexual identity and route of administration in relation to cannabis use among young adult females1
0.059689998626709